FORIMMUN

RESEARCH NETWORK FOR NEW STRATEGIES IN IMMUNOTHERAPY

Logo FORIMMUN

Tumor Vaccine

For tumor therapy, the identification of tumor-specific antigens and pathways of antigen presentation to the immune system is of major importance. Dendritic cells have been demonstrated to be extraordinary potent immunostimulators with the ability to enhance the immune response to tumor cells. Therefore, the use of dendritic cells in cancer immunotherapy is being explored. Another aim is the development of methods for specific elimination of tumor cells by the induction of programmed cell death.

Projects

  • T1 T1 - Identification and Characterization of Target Genes in B Cell Tumors
    more
  • T2 T2 - Therapy of solid tumors by adeno-associated virus
    more
  • T3 - Immuntherapy of tumors by specific tissue ablation
    more
  • T4 T4 - Bacteriological Tumortherapy
    more
  • T5 - RNA transfected dendritic cells as a tumor vaccine
    more

Information

Launching date

09.2002

End

03.2006

Funded by

Bayerische Forschungsstiftung